{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T16:36:44Z","timestamp":1788367004165,"version":"build-2803163510"},"reference-count":20,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1124\/dmd.118.080549","type":"journal-article","created":{"date-parts":[[2018,11,15]],"date-time":"2018-11-15T14:16:10Z","timestamp":1542291370000},"page":"104-113","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Characterization of Stereoselective Metabolism, Inhibitory Effect on Uric Acid Uptake Transporters, and Pharmacokinetics of Lesinurad Atropisomers"],"prefix":"10.1016","volume":"47","author":[{"given":"Chun","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongmei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zancong","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Renner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey N.","family":"Miner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Luc","family":"Girardet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline A.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.118.080549_bib1","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1517\/17425255.4.8.1065","article-title":"The effect of chronic renal failure on drug metabolism and transport","volume":"4","author":"Dreisbach","year":"2008","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1124\/dmd.118.080549_bib2","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0026-895X(25)11262-5","article-title":"The existence of stable enantiomers of telenzepine and their stereoselective interaction with muscarinic receptor subtypes","volume":"35","author":"Eveleigh","year":"1989","journal-title":"Mol Pharmacol"},{"key":"10.1124\/dmd.118.080549_bib3","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/00008571-199902000-00008","article-title":"The stereoselective metabolism of fluoxetine in poor and extensive metabolizers of sparteine","volume":"9","author":"Fjordside","year":"1999","journal-title":"Pharmacogenetics"},{"key":"10.1124\/dmd.118.080549_bib4","doi-asserted-by":"crossref","first-page":"4506","DOI":"10.1016\/j.bmc.2017.06.042","article-title":"Stable C-N axial chirality in 1-aryluracil scaffold and differences in in vitro metabolic clearance between atropisomers of PDE4 inhibitor","volume":"25","author":"Hasegawa","year":"2017","journal-title":"Bioorg Med Chem"},{"key":"10.1124\/dmd.118.080549_bib5","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1002\/cmdc.201000485","article-title":"Revealing atropisomer axial chirality in drug discovery","volume":"6","author":"LaPlante","year":"2011","journal-title":"ChemMedChem"},{"key":"10.1124\/dmd.118.080549_bib6","doi-asserted-by":"crossref","first-page":"7005","DOI":"10.1021\/jm200584g","article-title":"Assessing atropisomer axial chirality in drug discovery and development","volume":"54","author":"LaPlante","year":"2011","journal-title":"J Med Chem"},{"key":"10.1124\/dmd.118.080549_bib7","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1186\/s13075-016-1107-x","article-title":"Lesinurad, a novel, oral compound for gout, acts to decrease serum uric acid through inhibition of urate transporters in the kidney [published correction appears in Arthritis Res Ther 18:236]","volume":"18","author":"Miner","year":"2016","journal-title":"Arthritis Res Ther"},{"key":"10.1124\/dmd.118.080549_bib8","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1586\/ecp.10.143","article-title":"Modeling and predicting drug pharmacokinetics in patients with renal impairment","volume":"4","author":"Rowland Yeo","year":"2011","journal-title":"Expert Rev Clin Pharmacol"},{"key":"10.1124\/dmd.118.080549_bib9","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1111\/j.1538-7836.2010.04036.x","article-title":"Stereoselective interactions of warfarin enantiomers with the pregnane X nuclear receptor in gene regulation of major drug-metabolizing cytochrome P450 enzymes","volume":"8","author":"Rulcova","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1124\/dmd.118.080549_bib10","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1742-7843.2005.pto_194.x","article-title":"Influence of CYP2C9, 2C19 and 2D6 genetic polymorphisms on the steady-state plasma concentrations of the enantiomers of fluoxetine and norfluoxetine","volume":"97","author":"Scordo","year":"2005","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1124\/dmd.118.080549_bib11","first-page":"1","article-title":"Metabolism and disposition of lesinurad, a uric acid reabsorption inhibitor, in humans","volume":"12","author":"Shah","year":"2018","journal-title":"Xenobiotica"},{"key":"10.1124\/dmd.118.080549_bib13","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/cpdd.323","article-title":"Evaluation of pharmacokinetic interactions between lesinurad, a new selective urate reabsorption inhibitor, and commonly used drugs for gout treatment","volume":"6","author":"Shen","year":"2017","journal-title":"Clin Pharmacol Drug Dev"},{"key":"10.1124\/dmd.118.080549_bib14","first-page":"187","article-title":"Lesinurad (RDEA594), a novel investigational uricosuric agent for hyperuricemia and gout, blocks transport of uric acid induced by hydrochlorothiazide","volume":"70","author":"Tan","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1124\/dmd.118.080549_bib15","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/s41598-017-00706-7","article-title":"Discovery and characterization of verinurad, a potent and specific inhibitor of URAT1 for the treatment of hyperuricemia and gout","volume":"7","author":"Tan","year":"2017","journal-title":"Sci Rep"},{"key":"10.1124\/dmd.118.080549_bib16","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1021\/acsmedchemlett.6b00465","article-title":"Discovery and assessment of atropisomers of (\u00b1)-lesinurad","volume":"8","author":"Wang","year":"2017","journal-title":"ACS Med Chem Lett"},{"key":"10.1124\/dmd.118.080549_bib17","doi-asserted-by":"crossref","first-page":"9173","DOI":"10.1021\/acs.jmedchem.6b01088","volume":"59","author":"Watterson","year":"2016","journal-title":"J Med Chem"},{"key":"10.1124\/dmd.118.080549_bib18","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/S0006-2952(97)00304-3","article-title":"Human liver cytochrome P450 enzymes involved in the 7-hydroxylation of R- and S-warfarin enantiomers","volume":"54","author":"Yamazaki","year":"1997","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.118.080549_bib19","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.bmcl.2017.08.049","article-title":"Synthesis and biological evaluation of water-soluble derivatives of chiral gossypol as HIV fusion inhibitors targeting gp41","volume":"28","author":"Yang","year":"2018","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1124\/dmd.118.080549_bib20","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1177\/0091270004266622","article-title":"Simulation of the impact of atropisomer interconversion on plasma exposure of atropisomers of an endothelin receptor antagonist","volume":"44","author":"Zhou","year":"2004","journal-title":"J Clin Pharmacol"},{"key":"10.1124\/dmd.118.080549_bib21","unstructured":"ZURAMPIC (2015) Package insert. Ardea Biosciences, Inc., San Diego, CA."}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624078504?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624078504?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.118.080549","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T18:55:31Z","timestamp":1739904931000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955624078504"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["S0090955624078504"],"URL":"https:\/\/doi.org\/10.1124\/dmd.118.080549","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characterization of Stereoselective Metabolism, Inhibitory Effect on Uric Acid Uptake Transporters, and Pharmacokinetics of Lesinurad Atropisomers","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.118.080549","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}